RVRomi Vandoren

Romi Vandoren

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Romi Vandoren has a total of 45 co-authors. Here are the top co-authors by number of shared publications:

  • Pieter Meysman

    Adrem Data Lab, Department of Computer Science, University of Antwerp

    5 shared publications
  • Benson Ogunjimi

    Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing (AUDACIS), University of Antwerp, Antwerp, Belgium; Antwerp Center for Translational Immunology and Virology (ACTIV), Center for Health Economics Research and Modelling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Wilrijk, Belgium; Department of Paediatrics, Antwerp University Hospital, Edegem, Belgium

    4 shared publications
  • Esther Bartholomeus

    Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing (AUDACIS), University of Antwerp, Antwerp, Belgium; Antwerp Center for Translational Immunology and Virology (ACTIV), Center for Health Economics Research and Modelling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Wilrijk, Belgium

    4 shared publications
  • Kris Laukens

    Adrem Data Lab, Department of Computer Science, University of Antwerp, Antwerp, Belgium; Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing (AUDACIS), University of Antwerp, Antwerp, Belgium; Biomedical Informatics Network Antwerp (biomina), University of Antwerp, Antwerp, Belgium

    3 shared publications
  • Peter Delputte

    Laboratory for Microbiology, Parasitology and Hygiene, University of Antwerp, Wilrijk, Belgium

    3 shared publications
  • An Bervoets

    Department of Dermatology, Antwerp University Hospital and University of Antwerp

    2 shared publications

Latest Publications

  • Beyond the sequence : towards a systems-level understanding of T cell receptor repertoires and their broader microbial and environmental context

    by Romi Vandoren

    Our immune system relies on an enormous variety of T cell receptors (TCRs), the molecular sensors on T cells that recognise fragments of pathogens, tumours and the harmless microbes that live in and on us. Each receptor is created by a random genetic shuffling process during T cell development and is then shaped by selection in the thymus, by exposure to antigens and by the environment. The collection of receptors in one person, the TCR repertoire, therefore holds a record of that person’s immune history. Reading this record is difficult: the data are huge, noisy and highly complex. This thesis develops and applies computational frameworks to extract reproducible biological signals from TCR repertoires, with a focus on linking enriched receptor patterns to external factors such as the microbiome and disease. Its central methodological contribution is AIRRWAS (Adaptive Immune Receptor Repertoire-Wide Association Study), a framework that systematically links TCR repertoire patterns to the composition of the gut microbiome. Applied to three independent cohorts, covering healthy individuals, colorectal cancer patients and people with inflammatory bowel disease, AIRRWAS identified reproducible associations between TCRs and specific gut bacteria. Targeted bacterial stimulation experiments confirmed these predictions, making this, to our knowledge, the first framework to predict and functionally validate TCR-bacteria interactions at this resolution. The results show that the gut microbiome leaves a measurable, partly shared imprint on both the circulating and the mucosal T cell repertoire. This extends a principle known for persistent viruses such as cytomegalovirus and Epstein-Barr virus to bacteria of the gut. Beyond the microbiome, the thesis explores TCR signatures in Crohn’s disease, cancer immunotherapy and susceptibility to herpes zoster. In all these settings, TCR convergence, the repeated emergence of similar receptors through independent recombination events, proves to be a powerful principle: it separates antigen-driven signals from background recombination bias, even in the presence of technical noise and differences between cohorts. By combining convergence analysis, TCR clustering, epitope prediction and multimodal data integration, this work shows that TCR repertoires can be read not as lists of individual sequences, but as system-level records of immunological experience. This perspective has broad implications for immune monitoring, biomarker discovery and our understanding of adaptive immunity in health and disease.

  • Open Access

    Machine Learning for TCR Repertoire Epitope Annotation and Pattern Discovery

    by Romi Vandoren, Vincent Van Deuren, Fabio Affaticati, Sofie Gielis, Kris Laukens, Pieter Meysman

    T cells are central to adaptive immunity, recognizing antigenic peptides, called epitopes, via the T cell receptor (TCR). The immense diversity and cross‐reactivity of the TCR repertoire makes direct interpretation of antigen specificity from repertoire sequencing challenging. High‐throughput sequencing enables large‐scale profiling of TCRs but does not directly reveal their target epitopes, requiring computational approaches to bridge this gap. This review outlines two complementary strategies, bottom‐up and top‐down approaches, to annotate TCR specificity. Bottom‐up methods predict TCR‐epitope specificity from curated TCR‐epitope databases, identifying recurring patterns through distance‐based, feature‐based, or deep learning models. While effective for well‐characterized epitopes, they are limited by biased training data, absence of negative data, and weak generalization to unseen epitopes. Top‐down approaches instead infer antigen‐driven responses from repertoire‐level signals such as sequence similarity, enrichment, and TCR convergence. These methods enable discovery of disease‐ or exposure‐associated TCR signatures without prior epitope knowledge but are sensitive to technical noise and biological confounding. Both approaches are complementary as bottom‐up provides mechanistic specificity, while top‐down enables discovery in complex datasets. Their integration, alongside multimodal modeling and improved benchmarking, is key to advancing TCR‐epitope annotation and understanding adaptive immune responses.

  • Open Access

    AIRRWAS integrates TCR-microbiome data to reveal how the gut microbiome shapes the circulating and mucosal T cell repertoire

    by Romi Vandoren, My Ha, Vincent M.L. Van Deuren, Naomi De Roeck, Ting Pu, Eelco C. Brand, Maria Kuznetsova, Hajar Besbassi, Esther Bartholomeus, Fabio Affaticati, et al.

  • Open Access

    T cell-microbiome associations captured through T cell receptor convergence analysis

    by Romi Vandoren, My Ha, Vincent Van Deuren, Naomi De Roeck, Ting Pu, Eelco C. Brand, Maria Kuznetsova, Hajar Besbassi, Esther Bartholomeus, Fabio Affaticati, et al.

    The gut microbiome modulates mucosal immunity, yet how specific bacterial taxa shape the diversity and specificity of T cell receptor (TCR) repertoires remains poorly understood. Existing approaches emphasize single-species effects or broad immune features, without pinpointing which microbes drive specific T cell clonotypes. We present AIRRWAS, a computational framework that integrates TCR-microbiome interaction analysis with targeted in vitro validation to detect genus-level TCR convergence. Applied to three independent cohorts, AIRRWAS identified reproducible associations between convergent TCR clusters and 21 bacterial genera spanning core commensals, probiotics and taxa with immunomodulatory roles. Predicted clonotypes were enriched within the TCR–microbiome interaction network and preferentially activated by genus-matched stimuli, eliciting different functional T cell responses. These findings demonstrate that distinct repertoires can share genus-specific TCR motifs, enabling detection of shared immune signatures. AIRRWAS can map these TCR– microbiome interactions, laying the groundwork for biomarker discovery immune monitoring and the development of microbiome-targeted therapies.


  • Unraveling the Immune Signature of Herpes Zoster: Insights Into the Pathophysiology and Human Leukocyte Antigen Risk Profile

    by Romi Vandoren, Marlies Boeren, Jolien Schippers, Esther Bartholomeus, Kerry Mullan, Nele Michels, Olivier Aerts, Julie Leysen, An Bervoets, Julien Lambert, et al.

    The varicella-zoster virus (VZV) infects >95% of the population. VZV reactivation causes herpes zoster (HZ), known as shingles, primarily affecting the elderly and individuals who are immunocompromised. However, HZ can occur in otherwise healthy individuals. We analyzed the immune signature and risk profile in patients with HZ using a genome-wide association study across different UK Biobank HZ cohorts. Additionally, we conducted one of the largest HZ human leukocyte antigen association studies to date, coupled with transcriptomic analysis of pathways underlying HZ susceptibility. Our findings highlight the significance of the major histocompatibility complex locus for HZ development, identifying 5 protective and 4 risk human leukocyte antigen alleles. This demonstrates that HZ susceptibility is largely governed by variations in the major histocompatibility complex. Furthermore, functional analyses revealed the upregulation of type I interferon and adaptive immune responses. These findings provide fresh molecular insights into the pathophysiology and activation of innate and adaptive immune responses triggered by symptomatic VZV reactivation.


  • Open Access

    Unraveling the immune signature of herpes zoster: Insights into pathophysiology and the HLA risk profile

    by Romi Vandoren, Marlies Boeren, Jolien Schippers, Esther Bartholomeus, Nele Michels, Olivier Aerts, Julie Leysen, An Bervoets, Julien Lambert, Elke Leuridan, et al.

    The varicella-zoster virus (VZV) infects over 95% of the population and establishes latency afterwards. Reactivation of VZV causes herpes zoster (HZ), commonly known as shingles, which presents as a painful rash in mostly the elderly and people with a weakened immune system. However, HZ might occur in otherwise healthy individuals too. In this study, we have studied the immune signature of HZ to better understand HZ’s pathophysiology. We provide a general overview of the antiviral state and the activation of innate and adaptive immune responses during HZ. Differential gene expression and gene ontology analyses revealed upregulation of several genes and host immune pathways during herpes zoster, especially related to type I IFN response but also related to adaptive immune responses. Intriguingly, no differences in gene expression were noted during convalescence between HZ patients and controls. Furthermore, we conducted the largest HLA association study on HZ to date using the UK Biobank and identified seven protective and four risk HLA alleles associated with the development of herpes zoster. These findings reveal key genes and pathways involved in the host immune response to symptomatic VZV reactivation and provide new molecular insights into the development of HZ.